Connective Tissue Disorders and Fragile X Molecular Status in Females: A Case Series and Review

Connective Tissue Disorders and Fragile X Molecular Status in Females: A Case Series and Review

Fragile X syndrome (FXS) is the most common inherited cause of intellectual disabilities and the second most common cause after Down syndrome. FXS is an X-linked disorder due to a full mutation of the CGG triplet repeat of the <i>FMR1</i> gene which codes for a protein that is crucial in...

Full description

Bibliographic Details
Main Authors:	Merlin G. Butler, Waheeda A. Hossain, Jacob Steinle, Harry Gao, Eleina Cox, Yuxin Niu, May Quach, Olivia J. Veatch
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	International Journal of Molecular Sciences
Subjects:	<i>FMR1</i> gene fragile X syndrome <i>FMR1</i> gray zone or intermediate alleles connective tissue-related disorders
Online Access:	https://www.mdpi.com/1422-0067/23/16/9090

Similar Items

Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)
by: Maria Isabel Alvarez-Mora, et al.
Published: (2022-04-01)

Different Clinical Faces of the Same Gene Mutation: Fragile X Mental Retardation 1 Disorders
by: Burcu Asma, et al.
Published: (2021-09-01)

Fragile X Syndrome Caused by Maternal Somatic Mosaicism of <i>FMR1</i> Gene: Case Report and Literature Review
by: Maria Jose Gómez-Rodríguez, et al.
Published: (2022-09-01)

Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
by: Ramkumar Aishworiya, et al.
Published: (2022-12-01)

Efficient Delivery of <i>FMR1</i> across the Blood Brain Barrier Using AAVphp Construct in Adult <i>FMR1</i> KO Mice Suggests the Feasibility of Gene Therapy for Fragile X Syndrome
by: Kathryn K. Chadman, et al.
Published: (2023-02-01)

Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on <i>FMR1</i> Premutation
by: Flora Tassone, et al.
Published: (2023-09-01)

Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
by: Maria Jimena Salcedo-Arellano, et al.
Published: (2023-08-01)

Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series
by: Maria Jimena Salcedo-Arellano, et al.
Published: (2020-05-01)

PGT-M for Premature Ovarian Failure Related to CGG Repeat Expansion of the <i>FMR1</i> Gene
by: Tiziana Persico, et al.
Published: (2023-12-01)

<i>Drosophila melanogaster</i> as a Model to Study Fragile X-Associated Disorders
by: Jelena Trajković, et al.
Published: (2022-12-01)

Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
by: Cedrik Tekendo-Ngongang, et al.
Published: (2021-10-01)

A Genotype-Phenotype Study of High-Resolution <i>FMR1</i> Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments
by: Dejan B. Budimirovic, et al.
Published: (2020-09-01)

Variation of FMRP Expression in Peripheral Blood Mononuclear Cells from Individuals with Fragile X Syndrome
by: Jamie L. Randol, et al.
Published: (2024-03-01)

Fragile X Syndrome: From Molecular Aspect to Clinical Treatment
by: Dragana D. Protic, et al.
Published: (2022-02-01)

Observable Symptoms of Anxiety in Individuals with Fragile X Syndrome: Parent and Caregiver Perspectives
by: Reymundo Lozano, et al.
Published: (2022-09-01)

Depletion of Mitochondrial Components from Extracellular Vesicles Secreted from Astrocytes in a Mouse Model of Fragile X Syndrome
by: Byung Geun Ha, et al.
Published: (2021-01-01)

Cognitive Training Deep Dive: The Impact of Child, Training Behavior and Environmental Factors within a Controlled Trial of Cogmed for Fragile X Syndrome
by: Haleigh Scott, et al.
Published: (2020-09-01)

Fragile X syndrome - insight into what we know and prospects
by: Adam Strzoda, et al.
Published: (2023-04-01)

Cytogenetic and Molecular Investigation in Children with Possible Fragile X Syndrome
by: Onur Ozer, et al.
Published: (2012-04-01)

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications
by: Ana Maria Cabal-Herrera, et al.
Published: (2020-06-01)

DNA Methylation, Mechanisms of <i>FMR1</i> Inactivation and Therapeutic Perspectives for Fragile X Syndrome
by: Veronica Nobile, et al.
Published: (2021-02-01)

Of Men and Mice: Modeling the Fragile X Syndrome
by: Regina Dahlhaus
Published: (2018-03-01)

Ketogenic Diet Affects Sleep Architecture in C57BL/6J Wild Type and Fragile X Mice
by: Pamela R. Westmark, et al.
Published: (2023-09-01)

Expression of FMRpolyG in Peripheral Blood Mononuclear Cells of Women with Fragile X Mental Retardation 1 Gene Premutation
by: Xuan Phuoc Nguyen, et al.
Published: (2022-03-01)

A Postmortem MRI Study of Cerebrovascular Disease and Iron Content at End-Stage of Fragile X-Associated Tremor/Ataxia Syndrome
by: Jun Yi Wang, et al.
Published: (2023-07-01)

Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome
by: Ramkumar Aishworiya, et al.
Published: (2023-07-01)

Metformin treatment in young children with fragile X syndrome
by: Hazel Maridith B. Biag, et al.
Published: (2019-11-01)

Developmental aspects of FXAND in a man with the FMR1 premutation
by: Ellery Santos, et al.
Published: (2020-02-01)

Comparative Behavioral Phenotypes of Fmr1 KO, Fxr2 Het, and Fmr1 KO/Fxr2 Het Mice
by: Rachel Michelle Saré, et al.
Published: (2019-01-01)

The Use of “Retardation” in FRAXA, FMRP, FMR1 and Other Designations
by: Jonathan Herring, et al.
Published: (2022-03-01)

“Corp-Osa-Mente”, a Combined Psychosocial–Neuropsychological Intervention for Adolescents and Young Adults with Fragile X Syndrome: An Explorative Study
by: Federica Alice Maria Montanaro, et al.
Published: (2023-02-01)

Mouse models of fragile X-related disorders
by: Rob Willemsen, et al.
Published: (2023-02-01)

Maternal well-being and family adaptation during COVID-19 in fragile X syndrome
by: Heather Fielding-Gebhardt, et al.
Published: (2022-08-01)

Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the <i>Fmr1</i>-KO Mouse Model of Fragile X Syndrome
by: Marika Premoli, et al.
Published: (2023-07-01)

Mechanisms Driving the Emergence of Neuronal Hyperexcitability in Fragile X Syndrome
by: Pernille Bülow, et al.
Published: (2022-06-01)

AAV‐delivered diacylglycerol kinase DGKk achieves long‐term rescue of fragile X syndrome mouse model
by: Karima Habbas, et al.
Published: (2022-05-01)

Parallel learning and cognitive flexibility impairments between Fmr1 knockout mice and individuals with fragile X syndrome
by: Lauren M. Schmitt, et al.
Published: (2023-01-01)

Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)
by: Ellery Santos, et al.
Published: (2023-12-01)

High performing male with fragile X syndrome with an unmethylated FMR1 full mutation: The relevance of clinical and genetic correlations
by: Meg Shieh, et al.
Published: (2023-06-01)

Urine-Derived Epithelial Cell Lines: A New Tool to Model Fragile X Syndrome (FXS)
by: Marwa Zafarullah, et al.
Published: (2020-10-01)